Evidence map›Paper›PMID 42279095›Full record

ArticleJournal of clinical medicine2026

Use of Disopyramide in Obstructive Hypertrophic Cardiomyopathy: A European Insight.

Philippe Charron, Faizel Osman, Jean-Noel Trochu, Carla Zema, Michael Hurst, Belinda Sandler, François-Emery Cotté, Teresa Lemmer, Maite Tome Esteban

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Philippe CharronDepartment of Cardiology & Department of Genetics, Hôpital Universitaire Pitié-Salpêtrière, IHU-ICAN, INSERM 1166, AP-HP, Sorbonne Université, 75013 Paris, France.ORCID 0000-0002-1782-1118
Faizel OsmanInstitute of Cardio-Metabolic Medicine, University Hospitals Coventry and Warwickshire NHS Trust, Coventry CV2 2DX, UK.ORCID 0000-0002-3962-5118
Jean-Noel TrochuL'institut du Thorax, Hôpital Universitaire, Nantes Université, INSERM, Centre National de Recherche Scientifique, 44035 Nantes, France.ORCID 0000-0003-4742-281X
Carla ZemaBristol Myers Squibb, Princeton, NJ 08543, USA.
Michael HurstBristol Myers Squibb, Uxbridge UB8 1DH, UK.ORCID 0000-0001-9360-0280
Belinda SandlerBristol Myers Squibb, Uxbridge UB8 1DH, UK.ORCID 0000-0002-4103-3082
François-Emery CottéBristol Myers Squibb, 92506 Rueil-Malmaison, France.ORCID 0000-0002-6758-4552
Teresa LemmerBristol Myers Squibb, Uxbridge UB8 1DH, UK.
Maite Tome EstebanDepartment of Cardiology, St George's NHS Foundation Trust & St George's University of London, London SW17 0QT, UK.

Funding

Bristol Myers Squibb This work was supported by Bristol Myers Squibb. The journal publication fee for this manuscript was funded by Bristol Myers Squibb.
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

disopyramideguideline-directed treatmenthypertrophic cardiomyopathyleft ventricular outflow tract obstructionobstructiontherapy

Identifiers

PMID42279095
PMCPMC13258706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.